VivArt-X raises 660k€ pre-seed round

Venture Challenge alumnus VivArt-X has closed a pre-seed round of €660,000 to accelerate and further develop a proof-of-concept. VivArt-X is developing a degradable biomaterial to regenerate tissue, with which the company can help patients with breast cancer to improve the survival of the transplanted fat. The round is completed by Brabant Startup Fund, the Brabant Development Company (BOM), TU/e Participation Holding and a number of informal investors.

Source: Vivart-x


‹ News overview